Recent Finacing
Recent Raise
Cycuria Therapeutics is a preclinical biotech in Graz developing biologics that selectively target tumor cells and stem cells while preserving hematopoiesis; lead protein-based targeted therapy CUR-101 for AML.
Focus Areas
Recent Investors
Funding round
Investors